AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover
AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover BioSpace
What this means for you
An FDA action or an outbreak report changes what is available or advisable. The practical question is always whether existing coverage applies and what the out-of-pocket exposure is.